EUROAPI SA engages in manufacturing and supply of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
Quelle est la performance du prix de l'action EUROAPI SA ?
Le prix actuel de EUROAPI SA est de $1.71, il a augmenté de 10.32% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Euroapi S.A. ?
Euroapi S.A. appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Euroapi S.A. ?
La capitalisation boursière actuelle de Euroapi S.A. est de $162.7M
Est-ce que Euroapi S.A. est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 8 analystes ont établi des notations d'analystes pour Euroapi S.A., y compris 0 achat fort, 1 achat, 4 maintien, 6 vente et 0 vente forte